Insider · CIK 0001760857
Saumya Sutaria
Files at THC (TENET HEALTHCARE CORP). First filing Sep 12, 2025, latest Aug 26, 2026.
In brief
Saumya Sutaria files SEC Form 4 as CEO and director at THC (TENET HEALTHCARE CORP). Since Sep 12, 2025, Saumya Sutaria has reported 0 open-market buys worth $0 and 2 open-market sells worth $43M, the latest filed on Aug 26, 2026.
A track record needs three past buys with six months of prices behind them; Saumya Sutaria has 0, so none is measured yet.
The newest scored trade: sold $28M of THC on Aug 24, 2026, filed Aug 26, 2026, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $28M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
THC: TENET HEALTHCARE CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | TENET HEALTHCARE CORP | $28M 100,000 shares | -19% | +73% from low-1% from high | |
| 63Notable | TENET HEALTHCARE CORP | $15M 78,762 shares | -18% | +74% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 25, 2026 | THC TENET HEALTHCARE CORP | 50,000 0.06% of outstanding | $14M | Aug 25, 2026 | $14M |
| Aug 24, 2026 | THC TENET HEALTHCARE CORP | 50,000 0.06% of outstanding | $14M | Aug 24, 2026 | none |
| Sep 10, 2025 | THC TENET HEALTHCARE CORP | 78,762 0.09% of outstanding | $15M | Sep 10, 2025 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -13,344 | $278.17 | $3.7M | 520,220 | Aug 26, 2026 |
| Aug 24, 2026 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -36,656 | $278.90 | $10M | 483,564 | Aug 26, 2026 |
| Aug 25, 2026 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -17,220 | $273.34 | $4.7M | 466,344 | Aug 26, 2026 |
| Aug 25, 2026 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -24,881 | $274.10 | $6.8M | 441,463 | Aug 26, 2026 |
| Aug 25, 2026 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -7,899 | $275.26 | $2.2M | 433,564 | Aug 26, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | MOption exercise Common Stock | +22,417 | - | - | 661,340 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | MOption exercise Common Stock | +36,384 | - | - | 697,724 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -9,282 | $237.58 | $2.2M | 688,442 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -29,919 | $239.39 | $7.2M | 658,523 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -124,959 | $239.39 | $30M | 533,564 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | AGrant or award 2026 February Restricted Stock Unitsderivative | +36,092 | $0.00 | $0 | 36,092 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | MOption exercise 2024 February Restricted Stock Unitsderivative | -22,417 | $0.00 | $0 | 22,417 | Mar 3, 2026 |
| Feb 27, 2026 | THC TENET HEALTHCARE CORP | MOption exercise 2023 March Restricted Stock Unitsderivative | -36,384 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Feb 24, 2026 | THC TENET HEALTHCARE CORP | MOption exercise Common Stock | +18,242 | - | - | 638,923 | Feb 26, 2026 |
| Feb 24, 2026 | THC TENET HEALTHCARE CORP | MOption exercise 2025 Restricted Stock Unitsderivative | -18,242 | $0.00 | $0 | 36,486 | Feb 26, 2026 |
| Feb 13, 2026 | THC TENET HEALTHCARE CORP | AGrant or award Common Stock | +245,592 | $0.00 | $0 | 620,681 | Feb 17, 2026 |
| Dec 31, 2025 | THC TENET HEALTHCARE CORP | MOption exercise Common Stock | +13,016 | - | - | 381,699 | Jan 2, 2026 |
| Dec 31, 2025 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -6,610 | $198.72 | $1.3M | 375,089 | Jan 2, 2026 |
| Dec 31, 2025 | THC TENET HEALTHCARE CORP | MOption exercise 2025 January Restricted Stock Unitsderivative | -13,016 | $0.00 | $0 | 39,049 | Jan 2, 2026 |
| Sep 10, 2025 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -59,456 | $190.48 | $11M | 387,989 | Sep 12, 2025 |
| Sep 10, 2025 | THC TENET HEALTHCARE CORP | SOpen-market sale Common Stock | -19,306 | $191.70 | $3.7M | 368,683 | Sep 12, 2025 |
| Aug 29, 2025 | THC TENET HEALTHCARE CORP | MOption exercise Common Stock | +53,341 | - | - | 528,706 | Sep 2, 2025 |
| Aug 29, 2025 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -27,087 | $184.33 | $5.0M | 501,619 | Sep 2, 2025 |
| Aug 29, 2025 | THC TENET HEALTHCARE CORP | FTax withholding Common Stock | -54,174 | $184.33 | $10.0M | 447,445 | Sep 2, 2025 |
| Aug 29, 2025 | THC TENET HEALTHCARE CORP | MOption exercise 2021 September Restricted Stock Unitsderivative | -53,341 | $0.00 | $0 | 0 | Sep 2, 2025 |
| Aug 13, 2025 | THC TENET HEALTHCARE CORP | AGrant or award Common Stock | +106,682 | $0.00 | $0 | 475,365 | Aug 15, 2025 |
Questions about Saumya Sutaria
Answered from the filings on this page, as of the latest one.
Is Saumya Sutaria buying or selling?
In the last 12 months Saumya Sutaria reported 0 open-market buys worth $0 and 1 open-market sell worth $28M on SEC Form 4; the latest was sold $28M of THC on Aug 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Saumya Sutaria's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Saumya Sutaria has 0.
Where does Saumya Sutaria file Form 4?
Saumya Sutaria has filed Form 4 at THC (TENET HEALTHCARE CORP) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.